These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 1407006)
1. Effects of taurine, homotaurine and GABA on hypothalamic and striatal dopamine metabolism. Panula-Lehto E; Mäkinen M; Ahtee L Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):57-62. PubMed ID: 1407006 [TBL] [Abstract][Full Text] [Related]
2. Locally infused taurine, GABA and homotaurine alter differently the striatal extracellular concentrations of dopamine and its metabolites in rats. Ruotsalainen M; Majasaari M; Salimäki J; Ahtee L Amino Acids; 1998; 15(1-2):117-34. PubMed ID: 9871492 [TBL] [Abstract][Full Text] [Related]
3. Effects of intraventricular taurine, homotaurine and GABA on serum prolactin and thyrotropin levels in female and in male rats. Mäkinen M; Ahtee L; Rosenqvist K; Tuominen RK; Männistö P J Neural Transm Gen Sect; 1993; 94(3):155-63. PubMed ID: 8123228 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of intraventricular taurine, GABA and homotaurine on serum prolactin levels in male rats. Panula-Lehto E; Ahtee L; Tuominen RK; Männistö PT Pharmacol Toxicol; 1989 Aug; 65(2):152-6. PubMed ID: 2813286 [TBL] [Abstract][Full Text] [Related]
5. Effects of intranigral injection of taurine and GABA on striatal dopamine release monitored voltammetrically in the unanaesthetized rat. O'Neill RD Brain Res; 1986 Sep; 382(1):28-32. PubMed ID: 3768678 [TBL] [Abstract][Full Text] [Related]
6. Effects of systemic and intracerebroventricular domperidone treatment on striatal and hypothalamic dopaminergic neurons. Ferretti C; Benfenati F; Cimino M; Vantini G; Lipartiti M; Muccioli G; di Carlo R; Algeri S Med Biol; 1983; 61(6):331-6. PubMed ID: 6676604 [TBL] [Abstract][Full Text] [Related]
7. Effects of morphine treatment and withdrawal on striatal and limbic monoaminergic activity and ascorbic acid oxidation in the rat. Desole MS; Esposito G; Fresu L; Migheli R; Enrico P; Mura MA; De Natale G; Miele E; Miele M Brain Res; 1996 Jun; 723(1-2):154-61. PubMed ID: 8813393 [TBL] [Abstract][Full Text] [Related]
8. Chronic cocaine and rat brain catecholamines: long-term reduction in hypothalamic and frontal cortex dopamine metabolism. Karoum F; Suddath RL; Wyatt RJ Eur J Pharmacol; 1990 Sep; 186(1):1-8. PubMed ID: 2282931 [TBL] [Abstract][Full Text] [Related]
9. Effects of hypoxia and cytidine (5') diphosphocholine on the concentrations of dopamine, norepinephrine and metabolites in rat hypothalamus and striatum. Saligaut C; Daoust M; Moore N; Boismare F Arch Int Pharmacodyn Ther; 1987 Jan; 285(1):25-33. PubMed ID: 3579424 [TBL] [Abstract][Full Text] [Related]
10. Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P. Reid M; Herrera-Marschitz M; Hökfelt T; Terenius L; Ungerstedt U Eur J Pharmacol; 1988 Mar; 147(3):411-20. PubMed ID: 2454197 [TBL] [Abstract][Full Text] [Related]
11. Taurine and its derivatives alter brain dopamine metabolism similarly to GABA in mice and rats. Ahtee L; Vahala ML Prog Clin Biol Res; 1985; 179():331-41. PubMed ID: 4059218 [No Abstract] [Full Text] [Related]
12. Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat. Männistö PT; Tuomainen P Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):412-8. PubMed ID: 1766471 [TBL] [Abstract][Full Text] [Related]
14. Release of endogenous dopamine, 3,4-dihydroxyphenylacetic acid, and amino acid transmitters from rat striatal slices. Flint RS; Murphy JM; McBride WJ Neurochem Res; 1985 Apr; 10(4):515-27. PubMed ID: 2860579 [TBL] [Abstract][Full Text] [Related]
15. Dynamic characteristics of dopamine, norepinephrine and serotonin metabolism in axonal endings of the rat hypothalamus and striatum during hypoxia: a study using HPLC with electrochemical detection. Saligaut C; Chretien P; Daoust M; Moore N; Boismare F Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):343-9. PubMed ID: 2426539 [TBL] [Abstract][Full Text] [Related]
16. A microdialysis study on striatal dopamine, 5-HT and metabolites in conscious rats after various treatments: evidence for extravesicular release of dopamine. Wong PT; Teo WL; Lee T Neuroreport; 1993 Oct; 5(1):53-6. PubMed ID: 7506588 [TBL] [Abstract][Full Text] [Related]
17. Effect of vitamin B-6 nutrition on the levels of dopamine, dopamine metabolites, dopa decarboxylase activity, tyrosine, and GABA in the developing rat corpus striatum. Guilarte TR Neurochem Res; 1989 Jun; 14(6):571-8. PubMed ID: 2761676 [TBL] [Abstract][Full Text] [Related]
18. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice. Lin Z; Dodd CA; Filipov NM Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127 [TBL] [Abstract][Full Text] [Related]
19. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid. Steranka LR Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818 [TBL] [Abstract][Full Text] [Related]
20. Intracerebroventricular administration of neuropeptide Y affects parameters of dopamine, glutamate and GABA activities in the rat striatum. Kerkerian-Le Goff L; Forni C; Samuel D; Bloc A; Dusticier N; Nieoullon A Brain Res Bull; 1992 Feb; 28(2):187-93. PubMed ID: 1596740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]